Why XRF Scientific’s Fully Franked AUD 0.045 Dividend Matters to Investors
XRF Scientific Limited has announced a fully franked ordinary dividend of AUD 0.045 per share for the fiscal year ending June 2025, accompanied by a Dividend Reinvestment Plan offering a 2.5% discount.
- Ordinary fully franked dividend of AUD 0.045 per share
- Dividend payable on 26 September 2025
- Ex-dividend date set for 11 September 2025
- Dividend Reinvestment Plan (DRP) available with 2.5% discount
- DRP participation limited to shareholders in Australia and New Zealand
Dividend Announcement Overview
XRF Scientific Limited (ASX, XRF), a player in the scientific instruments sector, has declared an ordinary dividend of AUD 0.045 per share, fully franked at the 30% corporate tax rate. This dividend relates to the financial year ending 30 June 2025 and will be paid on 26 September 2025. The ex-dividend date is set for 11 September 2025, with the record date following on 12 September 2025.
Dividend Reinvestment Plan Details
Shareholders have the option to participate in a Dividend Reinvestment Plan (DRP), which offers a 2.5% discount on the reinvestment price. The DRP price will be calculated based on the volume-weighted average market price of shares traded over a five-day period starting three trading days after the record date. Importantly, the DRP securities will be newly issued and will rank equally with existing shares from the date of issue.
The deadline for shareholders to elect participation in the DRP is 15 September 2025 at 7, 00 pm. Participation is available exclusively to shareholders with registered addresses in Australia or New Zealand, reflecting the company’s regional shareholder base.
Implications for Shareholders and Market
This dividend announcement underscores XRF Scientific’s commitment to returning value to shareholders through a fully franked payout, which can be particularly attractive for investors seeking tax-effective income streams. The availability of the DRP with a discount provides an incentive for shareholders to reinvest dividends, potentially supporting share price stability and capital growth.
While the dividend amount is modest, it reflects the company’s steady financial position and ongoing profitability. However, the announcement does not provide forward guidance on dividend sustainability or growth, leaving investors to watch closely for future updates.
Bottom Line?
XRF Scientific’s fully franked dividend and DRP offer a balanced approach to shareholder returns, setting the stage for investor decisions ahead of the payment date.
Questions in the middle?
- Will XRF Scientific maintain or increase dividend payouts in the coming years?
- How many shareholders will opt into the DRP, and what impact will this have on share capital?
- What are the company’s growth prospects that underpin this dividend policy?
